HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takako Mitsumatsu Selected Research

Takako Mitsumatsu Research Topics

Disease

2Graves Disease (Basedow Disease)
06/2021 - 03/2021
1Thyroid Diseases (Thyroid Disease)
01/2022
1COVID-19
01/2022
1Disease Progression
06/2021
1Congenital Abnormalities (Deformity)
03/2021
1Neoplasms (Cancer)
04/2019
1Autoimmune Diseases (Autoimmune Disease)
04/2019
1Breast Neoplasms (Breast Cancer)
04/2019
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2019
1Fatigue
04/2019
1Hyperglycemia
04/2019
1Hypoglycemia (Reactive Hypoglycemia)
04/2019
1Hypotension (Low Blood Pressure)
04/2019
1Polydipsia
04/2019
1Diabetes Mellitus
01/2019

Drug/Important Bio-Agent (IBA)

1Thyroxine (Levothyroxine)FDA LinkGeneric
01/2022
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2022
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
06/2021
1thyrotropin-binding inhibitory immunoglobulinIBA
06/2021
1Antithyroid Agents (Antithyroid Drugs)IBA
03/2021
1PropylthiouracilFDA Link
03/2021
1SteroidsIBA
04/2019
1CTLA-4 AntigenIBA
04/2019
1Isolated ACTH DeficiencyIBA
04/2019
1NivolumabIBA
04/2019
1Blocking AntibodiesIBA
04/2019
1Glucagon (Glukagon)FDA Link
01/2019
1CanagliflozinIBA
01/2019
13- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA
01/2019
1Insulin (Novolin)FDA Link
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019

Therapy/Procedure

1Therapeutics
04/2019
1Drug Therapy (Chemotherapy)
04/2019